目次

SECTION I: EPIDEMIOLOGY AND PATHOPHYSIOLOGY 1 Epidemiology of Hypertension 2 Pathogenesis of Hypertension SECTION II: DIAGNOSIS 3 Defining Hypertension 4 Office Blood Pressure Measurement 5 Home Monitoring of Blood Pressure 6 Ambulatory Blood Pressure Monitoring in Clinical Hypertension Management 7 White Coat and Masked Hypertension 8 Secondary Hypertension: Renovascular Hypertension 9 Secondary Hypertension: Renin-Independent Mineralocorticoid Excess States 10 Secondary Hypertension: Pheochromocytoma 11 Secondary Hypertension: Sleep Apnea 12 Rare and Unusual Forms of Hypertension SECTION III: RISK STRATIFICATION 13 The Natural History of Untreated Hypertension 14 The Special Problem of Isolated Systolic Hypertension　 15 Assessment of Hypertensive Target Organ Damage 16 Prediction of Global Cardiovascular Risk in Hypertension SECTION IV: TREATMENT 17 Diet and Blood Pressure 18 Diuretic Therapy in Cardiovascular Disease 19 ?-Blockers in Hypertension 20 Angiotensin-Converting Enzyme Inhibitors 21 Angiotensin Receptor Blockers 22 Calcium Channel Blockers in Hypertension 23 ?-Blockers 24 New Drugs for Hypertension 25 Devices for Hypertension SECTION V: OUTCOME STUDIES 26 Design of Outcomes Studies 27 Meta-Analyses of Hypertension Trials: The Blood Pressure Lowering Treatment Trialists' Collaboration SECTION VI: HYPERTENSION AND CONCOMITANT DISEASES 28 Ischemic Heart Disease in Hypertension 29 Heart Failure in Hypertension 30 Kidney Disease in Hypertension 31 Transplant Hypertension 32 Obesity in Hypertension 33 Peripheral Artery Disease in Hypertension 34 Cerebrovascular Disease in Hypertension 35 Hypertension and Diabetes Mellitus: An Update 36 Dyslipidemia in Hypertension SECTION VII: SPECIAL POPULATIONS AND SPECIAL SITUATIONS 37 Hypertension in Pregnancy 38 Hypertension in Children and Adolescents 39 Hypertension in Older Patients 40 Hypertension in African Americans　 41 Hypertension in Hispanics 42 Hypertension in East Asians and Native Hawaiians 43 Hypertension in South Asians 44 Resistant Hypertension 45 Hypertension and the Perioperative Period 46 Hypertensive Emergencies and Urgencies SECTION VIII: HYPERTENSION TREATMENT IN THE FUTURE 47 Team-Based Care for the Management of Hypertension 48 Outcomes Research in Hypertension　 49 Pharmacogenetics of Antihypertensive Treatment 50 Antihypertensive Drug Development: A Regulatory Perspective SECTION IX: GUIDELINES 51 U.S. and Canadian Hypertension Guidelines 52 European and British Guidelines on Hypertension